PharmaNews.eu
  • Home
  • Business
  • R&D
  • EC
  • EMA
  • Events
  • Open Calls

Pfizer

Pfizer

PfizerFounded in 1849, Pfizer is the world's largest research-based pharmaceutical company. Pfizer is taking new approaches to advancing better health as it discovers, develops, manufactures and delivers quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. Pfizer also partners with healthcare providers, governments and local communities around the world to expand access to medicines and to provide better quality health care and health system support. At Pfizer, more than 84,000 colleagues in more than 90 countries work every day to help people stay happier and healthier longer and to reduce the human and economic burden of disease worldwide. For more information visit www.pfizer.com.

Pfizer RSS Channel

Filters
List of articles in category Pfizer
Title Published Date
Pfizer and BioNTech complete submission to European Medicines Agency for Omicron BA.1 adapted bivalent vaccine candidate 20 July 2022
Pfizer and BioNTech announce Omicron-adapted COVID-19 vaccine candidates demonstrate high immune response against Omicron 25 June 2022
Pfizer to acquire Biohaven Pharmaceuticals 10 May 2022
Pfizer shares top-line results from Phase 2/3 EPIC-PEP study of PAXLOVID™ for post-exposure prophylactic use 02 May 2022
Pfizer updates company position in Russia 16 March 2022
Pfizer receives CHMP positive opinion for novel COVID-19 oral treatment 01 February 2022
Pfizer and BioNTech initiate study to evaluate Omicron-based COVID-19 vaccine in adults 18 to 55 years of age 27 January 2022
Pfizer and BioNTech publish data from two laboratory studies on COVID-19 vaccine-induced antibodies ability to neutralize SARS-CoV-2 Omicron variant 25 January 2022
Pfizer shares in vitro efficacy of novel COVID-19 oral treatment against omicron variant 19 January 2022
Pfizer and BioNTech provide update on Omicron variant 08 December 2021
Pfizer's novel COVID-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of Phase 2/3 EPIC-HR study 05 November 2021
Pfizer and BioNTech announce Phase 3 trial data showing high efficacy of a booster dose of their COVID-19 vaccine 25 October 2021
Pfizer and BioNTech announce positive topline results from pivotal trial of COVID-19 vaccine in children 5 to 11 years 21 September 2021
Collaboration between AbbVie, Biogen and Pfizer creates world's largest browsable resource linking rare protein-coding genetic variants to human health and disease 15 July 2021
Pfizer and BioNTech to supply the European Union with up to 1.8 billion additional doses of COMIRNATY® 26 May 2021
Pfizer and BioNTech to provide COVID-19 caccine doses for olympic athletes at the 2020 Tokyo Games 06 May 2021
Pfizer-BioNTech announce positive topline results of pivotal COVID-19 vaccine study in adolescents 31 March 2021
Pfizer initiates Phase 1 study of novel oral antiviral therapeutic agent against SARS-CoV-2 24 March 2021
Pfizer and BioNTech initiate a study as part of broad development plan to evaluate COVID-19 booster and new vaccine variants 26 February 2021
Pfizer and BioNTech commence global clinical trial to evaluate COVID-19 vaccine in pregnant women 18 February 2021

Page 1 of 5

  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next
  • End
  1. You are here:  
  2. Home
  3. Pfizer

About

  • Home
  • Terms and Conditions
  • Contact

Advertise

Top News Channels

  • Business
  • Research
  • EMA
  • Events

Follow us

Didn't we got you connected? If not, please note the following magic buttons:

  • Facebook
  • Twitter
  • RSS 2.0
  • Atom 1.0

Newsletter

Stay updated on the latest Pharma News. Subscribe now, it's free!

Copyright © 2022 PharmaNews.eu. All Rights Reserved.